IceCure Medical (Nasdaq:ICCM) announced today that it received an intention to grant notice from the European Patent Office. The notice covers the company's invention titled "Cryogenic System Connector," which recently received a patent in the U.S., too. Caesarea, Israel-based IceCure designed it to work as part of its XSense cryoablation … [Read more...] about IceCure earns European patent win for next-gen cryoablation tech
IceCure Medical
IceCure Medical wins regulatory approval in China for disposable cryoprobes
IceCure Medical recently announced it received regulatory approval in China for its IceSense3 disposable cryoprobes. With the approval, the company and its partners in China can begin to treat malignant and benign tissue of the breast, lung, bone, liver and kidneys, as well as palliative interventions. "With approximately 430,000 new breast … [Read more...] about IceCure Medical wins regulatory approval in China for disposable cryoprobes
IceCure Medical wins minimally-invasive cryoablation catheter patent in Japan
IceCure Medical recently announced it received a patent in Japan for its cryogen pump for cryoablation procedures. Caesarea, Israel-based IceCure Medical's cryogenic pump is submersible in liquid nitrogen, works in a closed circuit and improves the cooling rate during a procedure. The company designed it for multiple or longer-duration … [Read more...] about IceCure Medical wins minimally-invasive cryoablation catheter patent in Japan
IceCure Medical wins FDA breakthrough device designation for cryoablation system
IceCure Medical today said it received FDA breakthrough device designation for its ProSense cryoablation system. ProSense is a liquid nitrogen-based cryoablation system that is a minimally invasive treatment for cancer tumors. It is designed for use in the treatment of TI invasive breast cancer or in patients not suitable for surgical … [Read more...] about IceCure Medical wins FDA breakthrough device designation for cryoablation system
